HealthAstraZeneca and Cleveland Clinic Abu Dhabi Launch $50 Million Clinical Trials Initiative
AstraZeneca is partnering with Cleveland Clinic Abu Dhabi to invest $50 million in conducting dozens of clinical trials focused on cardiovascular, renal, and metabolic diseases. The initiative aims to leverage AI and real-world data to improve patient outcomes and enhance the sustainability of healthcare systems.
The National|October 24, 2026 